Ambryon Biosciences

AAV2-R100 Serotype

AAV2 variant engineered for enhanced CNS penetration through rational capsid modification with improved neuronal transduction.

TropismCNS (neurons), reduced glial transduction

Characteristics

Single amino acid substitutions improve neuronal specificity. Reduced glial tropism compared to wild-type AAV2. Enhanced CNS penetration following systemic administration.

Applications

Neurological disorders requiring neuron-specific gene delivery. Preclinical CNS gene therapy research.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Qiao et al. (2017). Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Mol Ther — Qiao 2017 AAV2 Variants

Identifiers & revision